StockData
Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc. (HEPA) stock

HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)

Close on Oct 19, 2026Market cap $7.26MP/E –Yield –

Earnings

Hepion Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Hepion Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Hepion Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Hepion Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Hepion Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. News
  3. News
  4. News
  5. Update
  6. Update
  7. News
  8. News
  9. Update
  10. Update
  11. Update
  12. News
  13. News
  14. Update
  15. Update

See a number that looks wrong?